All

Launchmetrics acquires PARKLU, the premier influencer analytics platform in China
17 November 2020

Launchmetrics acquires PARKLU, the premier influencer analytics platform in China

The leading Brand Performance Cloud for the Fashion, Luxury & Beauty (FLB) industries, announces the acquisition of PARKLU, China’s premier influencer analytics platform.

Read the press release
MaaT Pharma Treats First Acute Myeloid Leukemia Patient in Phase 1 Clinical Trial to Evaluate Capsule Formulation of Microbiome Restoration Biotherapeutic
12 November 2020

MaaT Pharma Treats First Acute Myeloid Leukemia Patient in Phase 1 Clinical Trial to Evaluate Capsule Formulation of Microbiome Restoration Biotherapeutic

MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of the...

Read more
DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company’s Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions
9 November 2020

DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company’s Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions

A consumer dermatology company developing novel, personalized, microbiome-based solutions for acne and other skin conditions, announced today that it has closed a $6.73 million...

Read more
BiomX has dosed their first subject in their Phase 1a study of BX002 phage therapy for IBD
3 November 2020

BiomX has dosed their first subject in their Phase 1a study of BX002 phage therapy for IBD

BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the...

Read more
Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round
27 October 2020

Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round

Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round. The company develops monoclonal antibodies for oral...

Read the press release
Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies
7 October 2020

Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies

Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million...

Read more
Merger between Ateme and Anevia: signing of final agreements
7 October 2020

Merger between Ateme and Anevia: signing of final agreements

Following the announcement on July 31, 2020 of the entry into exclusive negotiations between ATEME and the main shareholders of Anevia and the completion, by these latest, of...

Read more
Izicap awarded “best Digital Loyalty Solution” by Juniper Research within their “Fintech & Payments Awards 2020”
2 October 2020

Izicap awarded “best Digital Loyalty Solution” by Juniper Research within their “Fintech & Payments Awards 2020”

This category recognises the most impactful & innovative financial products and services operating globally across numerous areas, including Retail & Payments, Banking, Fraud &...

Read more
LARQ, leading health and wellness hydration brand, announced today a round closure of $10 million in Series A funding
29 September 2020

LARQ, leading health and wellness hydration brand, announced today a round closure of $10 million in Series A funding

LARQ was started with a simple vision where innovative technology can be combined with inspirational design to help people access pristine drinking water easily and...

Read the press release
Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline
25 September 2020

Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

Galecto., a privately-held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced today the successful completion of a $64...

Read more

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse